Interestingly, while 80% of EBVaGC tumors display an activating mutation in PIK3CA, high CIMP breast tumors are strongly enriched for low mutation rates of PIK3CA, MAP2K4, and MAP3K1 [9,65]. Here, PIK3CA is linked to breast neoplasm.